Loading clinical trials...
Loading clinical trials...
Examine change in the magnitude of antidepressant effects as a function of number of TMS sessions and to determine whether extended treatment courses, beyond 30 and beyond 36 TMS sessions, result in i...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Neuronetics
Collaborators
NCT07523048 · Major Depressive Disorder (MDD)
NCT07226661 · Major Depressive Disorder (MDD)
NCT06793397 · Major Depressive Disorder (MDD), Depression in Adults, and more
NCT07025720 · Major Depressive Disorder (MDD), Suicidal Ideation
NCT06804525 · Major Depressive Episode (MDE), Major Depressive Disorder (MDD), and more
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions